Follow on Google News News By Tag * Blood Bank Testing * Blood Banking * Blood Banking Market * Transfusion Diagnostic Testing * Blood Banking Market Reports * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Future of Blood Banking Market: Growth Opportunities and Business Expansion StrategiesVPGMarketResearch.com is pleased to introduce a new seven-country, 800-page report designed to help suppliers identify and evaluate emerging business opportunities in the global blood banking market.
"Future of Blood Banking Market: Growth Opportunities and Business Expansion Strategies" (http://www.vpgmarketresearch.com/ To review or order this report, visit http://www.vpgmarketresearch.com/ Contact Robert Fisher Healthcare Research robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com Geographic Coverage - France - Germany - Italy - Japan - Spain - UK - USA This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next ten years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; Sales and Market Share Analysis Sales and market share estimates for leading suppliers of blood banking reagents and instruments, by country and individual product. Instrument Placements Annual placements and installed base of major automated and semi-automated analyzers, by supplier and model. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood banking tests, including NAT, by country and market segment: - Blood Centers - Plasma Fractionation Facilities - Hospitals - Commercial/Private Laboratories - Military Blood Banks Current and Emerging Products - Analysis of current and emerging blood banking tests. - Review of automated and semi-automated analyzers, including their operating characteristics, features, and selling prices. Technology Review - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Worldwide Market Overview - Estimates of facilities performing blood banking tests, by country. - Test volume and sales projections by country. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Methodology The report is based on combination of primary and secondary information sources, including interviews with blood bankers, laboratory directors, and executives of leading diagnostics companies in the U.S., five major European countries, and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted. Contains 800 pages and 240 tables Table of Contents I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests 1. Blood Typing and Grouping Tests a. ABO b. Antibody Panels c. Antibody Screening d. Antigen Typing e. Antiglobulin Test f. Crossmatch g. HLA Typing h. Rh i. Other Blood Groups 2. Infectious Disease Screening Tests a. AIDS b. Hepatitis c. Cytomegalovirus d. Syphilis e. West Nile Virus f. Parvovirus B19 g. Creutzfeldt- h. Malaria i. Chagas Disease j. Babesiosis 3. Pathogen Reduction 4. Leukocyte Reduction - Background - Methods B. Instrumentation Review Introduction 1. Abbott Architect i2000 Series 2. Abbott AxSYM 3. Abbott LCx 4. Abbott Prism 5. Abbott Quantum II 6. Beckman Coulter/Biomek FX 7. Beckman Coulter BloodTrack Courier 8. Beckman Coulter OLA2500 9. Beckman Coulter PK7100 10. Beckman Coulter PK7200 11. Beckman Coulter PK80 12. Beckman Coulter Tango 13. Bio-Rad Elite 14. Bio-Rad GeneScope 15. BioMerieux Bac/Alert 16. Gen-Probe Tigris 17. Grifols Diana 18. Immucor ABS2000 19. Immucor Galileo 20. Immucor Rosys Plato System 21. Nanosphere Verigen Series 22. Ortho AutoVue/ProVue 23. Ortho StarFame Combo 24. Ortho Summit Processor 25. Roche Cobas Amplicor 26. Roches Cobas s 201 27. Sarstedt PVS 28. Siemens BEP 2000 29. Siemens Quadriga 30. Siemens SDA 31. Tecan ELPHAtyper 32. Tecan Genesis FE500 33. Tecan Hemotyper 34. Tecan LS Series 35. Tecan MegaFlex 36. Tecan MiniSwift C. Major in Vitro Diagnostic Technologies And Their Potential Applications 1. Molecular Diagnostics a. Overview b. NAT 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays a. Technological Principle b. Enzyme Immunoassays (EIA) - Overview - ELISA - Enzyme Amplification c. Fluorescent Immunoassays - Fluorescence Polarization d. Luminescence - Chemiluminescence - Bioluminescence e. Latex Agglutination f. Immunoprecipitation 4. Microtitration Plates 5. Information Technology 6. Automation 7. Lasers 8. Robotics 9. Artificial Intelligence 10. Synthetic Red Cell Substitutes 11. Genetically Engineered Blood Components a. Albumin b. Factor VIII c. Alpha-2 Antiplasmin d. Antithrombin III e. Factor IX f. Von Willebrand's Factor g. Fibrinogen h. t-PA 12. Blood Preservation 13. Autologous Blood Transfusion/ D. Worldwide Market Overview 1. Business Environment 2. Market Structure 3. Market Size and Growth France Germany Italy Japan Spain U.K. U.S.A. Competitive Assessments - Abbott - Beckman Coulter - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio - Gen-Probe - Grifols - Immucor - Innogenetics - Ortho-Clinical Diagnostics - Orchid CellMark - Novartis Diagnostics - Proteome Sciences - Roche - Siemens - Tecan Contact Robert Fisher Healthcare Research robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com # # # Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries. During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide. VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|